Hansen Medical Announces 2008 Fourth Quarter Conference Call
29 1월 2009 - 2:17AM
Marketwired
Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in flexible
robotics and the developer of robotic technology for accurate 3D
control of catheter movement, announced today that it will release
its financial and operating results for the fourth quarter ended
December 31, 2008 after market close on Thursday, February 12,
2009.
Hansen Medical will host a conference call at 5:00 p.m. ET (2:00
p.m. PT) on February 12, 2009 to discuss its results. The call may
be accessed by dialing 800-754-1053 (303-262-2053 for international
callers) and via the Internet in the Investor Relations section of
Hansen Medical's website at www.hansenmedical.com. Please go to the
website at least 15 minutes early to register, download and install
any necessary audio software. Following the call, a webcast replay
will be available on Hansen Medical's website, and an audio replay
will also be available by calling 800-405-2236 (303-590-3000 for
international callers) and entering the passcode 11125891. The
audio replay will be available through February 19, 2009.
About Hansen Medical, Inc.
Hansen Medical Inc., based in Mountain View, Calif., develops
products and technology using robotics for the accurate
positioning, manipulation and control of catheters and
catheter-based technologies. Its first product, the Sensei(TM)
Robotic Catheter system, is a robotic navigation system that
enables clinicians to place mapping catheters in hard-to-reach
anatomical locations within the heart easily, accurately and with
stability during complex cardiac arrhythmia procedures. The Sensei
system is compatible with fluoroscopy, ultrasound, 3D surface map
and patient electrocardiogram data and was cleared by the U.S. Food
and Drug Administration (FDA) in May 2007 for manipulation and
control of certain mapping catheters in Electrophysiology (EP)
procedures. The safety and effectiveness of the Sensei system for
use with cardiac ablation catheters in the treatment of cardiac
arrhythmias, including atrial fibrillation (AF), have not been
established. In the European Union, the Sensei system is cleared
for use during EP procedures, such as guiding catheters in the
treatment of AF. Additional information can be found at
www.hansenmedical.com.
Investor Contact: Steven Van Dick 650.404.5800 Email Contact
Media Contact: Amy Cook 925.552.7893 Email Contact Lasse Glassen
Financial Relations Board 213.486.6546 Email Contact
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (NASDAQ:HNSN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024
Hansen Medical, Inc. (MM) (나스닥)의 실시간 뉴스: 최근 기사 0
More Hansen Medical, Inc. News Articles